Business Insider2y
CRISPR pioneer Feng Zhang is building a secretive new startup trying to solve gene editing's biggest problem: getting into more parts of the body
The CRISPR pioneer Feng Zhang is launching yet another ambitious gene-editing startup, backed by approximately $200 million from some of biotech's biggest investors. The Cambridge, Massachusetts ...
Science News5y
Conversations with Maya: Feng Zhang
Maya Ajmera, President & CEO of Society for Science & the Public and Publisher of Science News, chatted with Feng Zhang, a Core Institute Member of the Broad Institute, a Professor at MIT ...
Microbiome study finds bacteria in human gut rarely update their CRISPR defense systems
Within the human digestive tract are trillions of bacteria from thousands of different species. These bacteria form ...
EurekAlert!3y
Feng Zhang, Broad Institute (IMAGE)
This is a photo of Feng Zhang. This material relates to a paper ... "C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector." ...
Fortune5y
Feng Zhang
The technology at the heart of that discovery is what’s known as Crispr, and Zhang is one of the scientists who pioneered its use in human cells, sparking a flurry of interest in using Crispr to ...